Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ymc
    Senior Member
    • Mar 2010
    • 496

    #1

    Ion S5 550 Chip - a serious competitor to NextSeq?



    It was announced two weeks ago. It can generate 26Gbp (200bp x 130M reads) in 3.5 hours.

    Not sure about the chip and reagent cost but the previous S5 540 chip's per Gbp cost is only double that of NextSeq 2x150 mode. I suspect 550 with 62.5% more throughput should be more competitive.

    If you are doing amplicon that typical requires either 200bp single from Ion or 2x150bp PE from NextSeq, it will become an even better deal.

    I have been working with Illumina data all the time. I am thinking seriously of switching to Ion because of this. I am worried about Ion's read quality though. How does its data compare to data generated by NextSeq 500/550?
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Do you know if people are buying Ion in your part of the world?

    Comment

    • ymc
      Senior Member
      • Mar 2010
      • 496

      #3
      Originally posted by GenoMax View Post
      Do you know if people are buying Ion in your part of the world?
      Not really. Just one or two machines in the universities as far as I know.

      Previously, Ion was not on my radar because there remains gaps in performance. Now the gap seems to be gone and it seems like I am going to do quite a bit of amplicon, so Ion seems to make more sense now.

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        I have not seen any new ion around where I am either. I assume you are thinking of getting the sequencing done from an external provider then?

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:13 AM
        0 responses
        16 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, Yesterday, 10:48 AM
        0 responses
        17 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        35 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        42 views
        0 reactions
        Last Post SEQadmin2  
        Working...